There were 1,761 press releases posted in the last 24 hours and 359,466 in the last 365 days.

Senate Bill 487 Printer's Number 516

PENNSYLVANIA, April 8 - PRINTER'S NO. 516

THE GENERAL ASSEMBLY OF PENNSYLVANIA

SENATE BILL

No.

487

Session of

2021

INTRODUCED BY SABATINA, FONTANA, SCHWANK AND HAYWOOD,

APRIL 8, 2021

REFERRED TO JUDICIARY, APRIL 8, 2021

AN ACT

Amending the act of April 14, 1972 (P.L.233, No.64), entitled

"An act relating to the manufacture, sale and possession of

controlled substances, other drugs, devices and cosmetics;

conferring powers on the courts and the secretary and

Department of Health, and a newly created Pennsylvania Drug,

Device and Cosmetic Board; establishing schedules of

controlled substances; providing penalties; requiring

registration of persons engaged in the drug trade and for the

revocation or suspension of certain licenses and

registrations; and repealing an act," further providing for

administration of the act by requiring notification regarding

theft or loss of controlled substances.

The General Assembly of the Commonwealth of Pennsylvania

hereby enacts as follows:

Section 1. Section 34 of the act of April 14, 1972 (P.L.233,

No.64), known as The Controlled Substance, Drug, Device and

Cosmetic Act, is amended by adding a subsection to read:

Section 34. Administration of Act.--* * *

(c.1) If a controlled substance is stolen from or there is a

loss of controlled substances at a nursing home or assisted

living facility, pharmacy or hospital, the nursing home,

assisted living facility, pharmacy or hospital shall promptly

provide notice of the theft or loss to appropriate local law

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.